We are live on ! Find out more
MCM

Moore Capital Management Portfolio holdings

AUM $4.92B
1-Year Est. Return 35.41%
This Fund
S&P 500
This Quarter Est. Return
+13.3%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$3.06B
AUM Growth
+$552M
Cap. Flow
+$311M
Cap. Flow %
10.15%
Top 10 Hldgs %
30.14%
Holding
419
New
114
Increased
43
Reduced
45
Closed
184

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.08%
2 Financials 13.21%
3 Technology 11.35%
4 Communication Services 9.18%
5 Consumer Staples 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LULU icon
76
lululemon athletica
LULU
$13.7B
$11.6M 0.38%
50,000
-25,000
-33% -$5.33M
FIVE icon
77
Five Below
FIVE
$11.5B
$11.5M 0.38%
90,000
-35,000
-28% -$4.38M
NXPI icon
78
NXP Semiconductors
NXPI
$65.4B
$11.5M 0.37%
90,000
+25,000
+38% +$2.9M
LHX icon
79
L3Harris
LHX
$56.9B
$11.4M 0.37%
+57,500
New +$11.5M
BBL
80
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$11M 0.36%
234,244
LLY icon
81
Eli Lilly
LLY
$1.09T
$10.9M 0.36%
+83,162
New +$9.64M
QSR icon
82
Restaurant Brands International
QSR
$26B
$10.7M 0.35%
168,529
-6,471
-4% -$433K
AYX
83
DELISTED
Alteryx Inc
AYX
$10.5M 0.34%
+105,000
New +$10.7M
USFD icon
84
US Foods
USFD
$22.3B
$10.5M 0.34%
250,000
-250,000
-50% -$10M
BMY icon
85
Bristol-Myers Squibb
BMY
$130B
$10.3M 0.34%
160,116
-39,709
-20% -$2.27M
PTCT icon
86
PTC Therapeutics
PTCT
$6.25B
$10.1M 0.33%
210,611
-27,844
-12% -$1.18M
LPX icon
87
Louisiana-Pacific
LPX
$5.35B
$9.91M 0.32%
334,164
+84,164
+34% +$2.38M
RTX icon
88
RTX Corp
RTX
$295B
$9.85M 0.32%
+104,477
New +$9.48M
ZEN
89
DELISTED
ZENDESK INC
ZEN
$9.58M 0.31%
+125,000
New +$9.15M
BIG
90
DELISTED
Big Lots, Inc.
BIG
$9.33M 0.31%
+325,000
New +$7.5M
WMGI
91
DELISTED
Wright Medical Group Inc
WMGI
$9.14M 0.3%
+300,000
New +$7.85M
CME icon
92
CME Group
CME
$93.5B
$9.03M 0.3%
45,000
-60,032
-57% -$12.3M
BOLD
93
DELISTED
Audentes Therapeutics, Inc
BOLD
$8.98M 0.29%
+150,000
New +$5.63M
BOLD
94
PUT
DELISTED
Audentes Therapeutics, Inc
BOLD
$8.98M 0.29%
+150,000
New +$5.63M
ADBE icon
95
Adobe
ADBE
$99B
$8.88M 0.29%
26,925
-28,075
-51% -$8.26M
ACAD icon
96
Acadia Pharmaceuticals
ACAD
$4.45B
$8.56M 0.28%
200,000
-41,653
-17% -$1.81M
MDCO
97
DELISTED
Medicines Co
MDCO
$8.49M 0.28%
+100,000
New +$6.67M
MDCO
98
PUT
DELISTED
Medicines Co
MDCO
$8.49M 0.28%
+100,000
New +$6.67M
TOL icon
99
Toll Brothers
TOL
$14.5B
$8.46M 0.28%
+214,180
New +$8.56M
NVDA icon
100
NVIDIA
NVDA
$4.77T
$8.24M 0.27%
1,400,000
-1,000,000
-42% -$5.2M

Similar funds

Moore Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Moore Capital Management held 419 positions worth $3.06B, up 22% from $2.51B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Moore Capital Management deployed $311M of net new capital in Q4 2019, opening 114 new positions and adding to 43 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,020,000 shares worth $89.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Apollo Global Management, an estimated $45M trimmed.

  • Moore Capital Management's largest Q4 2019 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,020,000 shares worth $89.7M.
  • Moore Capital Management added most to Amazon in Q4 2019, an estimated $74.5M increase.
  • Moore Capital Management's biggest Q4 2019 reduction was Apollo Global Management, cutting an estimated $45M.
  • Moore Capital Management fully exited Interxion Holding N.V. in Q4 2019, selling an estimated $60.3M.
  • Moore Capital Management's ten largest holdings make up 30% of its $3.06B portfolio in Q4 2019.
  • Moore Capital Management opened 114 new positions and closed 184 in Q4 2019.
  • Moore Capital Management's portfolio value rose 22% quarter-over-quarter to $3.06B.

Based on Moore Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.